Andrew Kramar

6.7k total citations
102 papers, 4.6k citations indexed

About

Andrew Kramar is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Andrew Kramar has authored 102 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 22 papers in Pulmonary and Respiratory Medicine and 20 papers in Surgery. Recurrent topics in Andrew Kramar's work include Statistical Methods in Clinical Trials (16 papers), Breast Cancer Treatment Studies (12 papers) and Testicular diseases and treatments (10 papers). Andrew Kramar is often cited by papers focused on Statistical Methods in Clinical Trials (16 papers), Breast Cancer Treatment Studies (12 papers) and Testicular diseases and treatments (10 papers). Andrew Kramar collaborates with scholars based in France, United States and Belgium. Andrew Kramar's co-authors include Caroline Mollévi, Joëlle Simony-Lafontaine, Catherine Hill, Monique G. Lê, T. Lacornerie, Éric Lartigau, Marc Ychou, Jean Grenier, Stéphane Culine and Alain Lortholary and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Andrew Kramar

102 papers receiving 4.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Andrew Kramar 1.9k 1.1k 1.1k 1.1k 809 102 4.6k
Anthony M. Magliocco 1.8k 0.9× 1.3k 1.2× 1.1k 1.0× 452 0.4× 853 1.1× 136 4.2k
Alexander Reinthaller 2.2k 1.1× 1.3k 1.2× 895 0.8× 2.1k 2.0× 933 1.2× 273 7.2k
Thomas Brunner 2.9k 1.5× 1.5k 1.4× 1.9k 1.8× 1.5k 1.4× 908 1.1× 170 5.9k
David Boulware 1.5k 0.8× 1.6k 1.4× 924 0.9× 1.7k 1.6× 845 1.0× 122 5.4k
Jing Gao 1.9k 1.0× 1.7k 1.6× 1.4k 1.3× 673 0.6× 1.1k 1.3× 240 4.6k
Hiroyuki Katoh 1.8k 0.9× 1.4k 1.3× 1.5k 1.4× 807 0.8× 633 0.8× 163 4.6k
Harvey J. Mamon 1.8k 0.9× 1.3k 1.2× 1.4k 1.3× 1.2k 1.1× 748 0.9× 154 4.5k
Mourad Tighiouart 1.7k 0.9× 1.6k 1.5× 930 0.9× 647 0.6× 700 0.9× 152 5.0k
William N. William 2.0k 1.0× 893 0.8× 1.5k 1.4× 901 0.9× 559 0.7× 109 4.0k
Jiro Okami 1.7k 0.9× 943 0.9× 3.0k 2.9× 827 0.8× 904 1.1× 156 5.0k

Countries citing papers authored by Andrew Kramar

Since Specialization
Citations

This map shows the geographic impact of Andrew Kramar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Kramar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Kramar more than expected).

Fields of papers citing papers by Andrew Kramar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Kramar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Kramar. The network helps show where Andrew Kramar may publish in the future.

Co-authorship network of co-authors of Andrew Kramar

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Kramar. A scholar is included among the top collaborators of Andrew Kramar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Kramar. Andrew Kramar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pivot, Xavier, Thomas Suter, J.-M. Nabholtz, et al.. (2015). Cardiac toxicity events in the PHARE trial, an adjuvant trastuzumab randomised phase III study. European Journal of Cancer. 51(13). 1660–1666. 49 indexed citations
2.
Ezzalfani, Monia, Audrey Emmanuelle Dugué, Caroline Mollévi, et al.. (2015). Le rôle des cohortes d’expansion dans les essais de phase I en cancérologie : des recommandations du HUB phase I. Bulletin du Cancer. 102(1). 73–82. 4 indexed citations
3.
Brodowicz, Thomas, Emmanuelle Tresch, S. Taïeb, et al.. (2015). Study protocol of REGOSARC trial: activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trial. BMC Cancer. 15(1). 127–127. 17 indexed citations
4.
Leclerc, Mathieu, Éric Lartigau, T. Lacornerie, et al.. (2015). Primary tumor delineation based on 18FDG PET for locally advanced head and neck cancer treated by chemo-radiotherapy. Radiotherapy and Oncology. 116(1). 87–93. 49 indexed citations
5.
Jarraya, H., Emmanuelle Tresch, F. Bonodeau, et al.. (2014). Novel Technique for Hepatic Fiducial Marker Placement for Stereotactic Body Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 90(1). 119–125. 14 indexed citations
6.
Pivot, X., Gilles Romieu, Marc Debled, et al.. (2013). 6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial. The Lancet Oncology. 14(8). 741–748. 211 indexed citations
7.
Adenis, Antoine, Emmanuelle Tresch, S. Dewas, et al.. (2013). Clinical complete responders to definite chemoradiation or radiation therapy for oesophageal cancer: predictors of outcome. BMC Cancer. 13(1). 413–413. 29 indexed citations
8.
Lorch, Anja, Andrew Kramar, Christian Kollmannsberger, et al.. (2012). Sequential Versus Single High-Dose Chemotherapy in Patients With Relapsed or Refractory Germ Cell Tumors: Long-Term Results of a Prospective Randomized Trial. Journal of Clinical Oncology. 30(8). 800–805. 66 indexed citations
9.
Fumagalli, I., Jean‐Emmanuel Bibault, S. Dewas, et al.. (2012). A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases. Radiation Oncology. 7(1). 164–164. 38 indexed citations
10.
Olmos, David, Charles Ferté, Philippe A. Cassier, et al.. (2012). Life-expectancy of patients enrolled in phase 1 clinical trials: A systematic review of published prognostic models. Critical Reviews in Oncology/Hematology. 83(2). 242–248. 19 indexed citations
11.
Filleron, Thomas, Jocelyn Gal, & Andrew Kramar. (2012). Designing group sequential randomized clinical trials with time to event end points using a R function. Computer Methods and Programs in Biomedicine. 108(1). 113–128. 3 indexed citations
12.
Kramar, Andrew, S. Dewas, Bernard Coche‐Dequeant, et al.. (2012). Salvage Stereotactic Reirradiation With or Without Cetuximab for Locally Recurrent Head-and-Neck Cancer: A Feasibility Study. International Journal of Radiation Oncology*Biology*Physics. 84(1). 203–209. 81 indexed citations
13.
Michiels, Stefan, Andrew Kramar, & Serge Koscielny. (2011). Multidimensionality of microarrays: Statistical challenges and (im)possible solutions. Molecular Oncology. 5(2). 190–196. 13 indexed citations
14.
Desmetz, Caroline, Caroline Mollévi, Philippe Rochaix, et al.. (2009). Identification of a New Panel of Serum Autoantibodies Associated with the Presence of In situ Carcinoma of the Breast in Younger Women. Clinical Cancer Research. 15(14). 4733–4741. 87 indexed citations
15.
16.
Granci, V., Frédéric Bibeau, Andrew Kramar, et al.. (2008). Prognostic significance of TRAIL-R1 and TRAIL-R3 expression in metastatic colorectal carcinomas. European Journal of Cancer. 44(15). 2312–2318. 22 indexed citations
17.
18.
Lambin, Philippe, A. Gerbaulet, Andrew Kramar, et al.. (1994). A comparison of early effects with two dose rates in brachytherapy of cervix carcinoma in a prospective randomised trial. European Journal of Cancer. 30(3). 312–320. 12 indexed citations
19.
Lambin, Philippe, A Gerbaulet, Andrew Kramar, et al.. (1993). Phase III trial comparing two low dose rates in brachytherapy of cervix carcinoma: Report at two years. International Journal of Radiation Oncology*Biology*Physics. 25(3). 405–412. 44 indexed citations
20.
Green, Mark R., Andrew Kramar, Richard L. Schilsky, et al.. (1990). Platinum‐based combination chemotherapy in advanced non‐small cell lung cancer: A randomized phase II trial of the cancer and leukemia group B. Medical and Pediatric Oncology. 18(3). 197–202. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anthony M. Magliocco Breakdown of academic impact, for papers by Alexander Reinthaller Breakdown of academic impact, for papers by Thomas Brunner Breakdown of academic impact, for papers by David Boulware Breakdown of academic impact, for papers by Jing Gao Breakdown of academic impact, for papers by Hiroyuki Katoh Breakdown of academic impact, for papers by Harvey J. Mamon Breakdown of academic impact, for papers by Mourad Tighiouart Breakdown of academic impact, for papers by William N. William Breakdown of academic impact, for papers by Jiro Okami
Rankless by CCL
2026